{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:08:48Z","timestamp":1784772528557,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ajp.2019.04.006","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T11:13:40Z","timestamp":1556363620000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The relationship between serum adiponectin levels, cardiometabolic indices and metabolic syndrome in schizophrenia"],"prefix":"10.1016","volume":"43","author":[{"given":"Yi Hang","family":"Tay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ajp.2019.04.006_bib0005","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.ajp.2019.04.006_bib0010","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4088\/JCP.v65n0417","article-title":"Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics","volume":"65","author":"Almeras","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.ajp.2019.04.006_bib0015","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.4088\/JCP.v68n1202","article-title":"Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia","volume":"68","author":"Bai","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2019.04.006_bib0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.psyneuen.2015.03.012","article-title":"Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: a meta-analysis","volume":"56","author":"Bartoli","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"10.1016\/j.ajp.2019.04.006_bib0025","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action","volume":"7","author":"Berg","year":"2001","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.ajp.2019.04.006_bib0030","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.psyneuen.2012.04.001","article-title":"Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome","volume":"37","author":"Beumer","year":"2012","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"10.1016\/j.ajp.2019.04.006_bib0035","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.pnpbp.2011.07.014","article-title":"Association of plasma retinol-binding protein-4, adiponectin, and high molecular weight adiponectin with metabolic adversities in patients with schizophrenia","volume":"35","author":"Chen","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2019.04.006_bib0040","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.psyneuen.2018.03.021","article-title":"Leptin\/adiponectin ratio as a potential biomarker for metabolic syndrome in patients with schizophrenia","volume":"92","author":"Chen","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.ajp.2019.04.006_bib0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-003-1074-z","article-title":"Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex","volume":"46","author":"Cnop","year":"2003","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.ajp.2019.04.006_bib0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.annepidem.2010.10.011","article-title":"Serum adiponectin in relation to body mass index and other correlates in black and white women","volume":"21","author":"Cohen","year":"2011","journal-title":"Ann. Epidemiol."},{"issue":"6","key":"10.1016\/j.ajp.2019.04.006_bib0055","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/070674370605100608","article-title":"Insulin resistance and adiponectin levels in drug-free patients with schizophrenia: a preliminary report","volume":"51","author":"Cohn","year":"2006","journal-title":"Can. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.ajp.2019.04.006_bib0060","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1172\/JCI14120","article-title":"Endogenous glucose production is inhibited by the adipose-derived protein Acrp30","volume":"108","author":"Combs","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ajp.2019.04.006_bib0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.schres.2005.12.855","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication","volume":"83","author":"De Hert","year":"2006","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.ajp.2019.04.006_bib0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/JCP.0b013e318166f533","article-title":"Beyond the \"hype\" on the association between metabolic syndrome and atypical antipsychotics: the confounding effects of cohort, typical antipsychotics, severe mental illness, comedications, and comorbid substance use","volume":"28","author":"de Leon","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.ajp.2019.04.006_bib0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1871529X11313010007","article-title":"Modulation of cardiovascular function by adipokines","volume":"13","author":"DeClercq","year":"2013","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"10.1016\/j.ajp.2019.04.006_bib0080","series-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I\/P)","author":"First","year":"2002"},{"key":"10.1016\/j.ajp.2019.04.006_bib0085","series-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I\/NP)","author":"First","year":"2002"},{"issue":"6","key":"10.1016\/j.ajp.2019.04.006_bib0090","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1590\/2359-3997000000316","article-title":"Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes: a literature review","volume":"61","author":"Frankenberg","year":"2017","journal-title":"Arch. Endocrinol. Metab."},{"issue":"2\u20133","key":"10.1016\/j.ajp.2019.04.006_bib0095","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.psychres.2012.03.043","article-title":"Prevalence of metabolic syndrome in patients with schizophrenia in India","volume":"200","author":"Grover","year":"2012","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.ajp.2019.04.006_bib0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00132577-200512000-00018","article-title":"Diagnosis and management of the metabolic syndrome: an american heart Association\/National heart, lung, and blood institute scientific statement: executive summary","volume":"4","author":"Grundy","year":"2005","journal-title":"Crit. Pathw. Cardiol."},{"issue":"2\u20133","key":"10.1016\/j.ajp.2019.04.006_bib0105","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.schres.2008.09.008","article-title":"A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder","volume":"106","author":"Hanssens","year":"2008","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.ajp.2019.04.006_bib0110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.atherosclerosis.2005.07.020","article-title":"Modification of the NCEP ATP III definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease","volume":"186","author":"Heng","year":"2006","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.ajp.2019.04.006_bib0115","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.HYP.0000129281.03801.4b","article-title":"Hypoadiponectinemia is an independent risk factor for hypertension","volume":"43","author":"Iwashima","year":"2004","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.ajp.2019.04.006_bib0120","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.3390\/ijms15046184","article-title":"Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease","volume":"15","author":"Jung","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ajp.2019.04.006_bib0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"9","key":"10.1016\/j.ajp.2019.04.006_bib0130","doi-asserted-by":"crossref","first-page":"787","DOI":"10.5551\/jat.11833","article-title":"Adiponectin and smoking status: a systematic review","volume":"19","author":"Kotani","year":"2012","journal-title":"J. Atheroscler. Thromb."},{"issue":"12","key":"10.1016\/j.ajp.2019.04.006_bib0135","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/070674371005501202","article-title":"The epidemiology of excess mortality in people with mental illness","volume":"55","author":"Lawrence","year":"2010","journal-title":"Can. J. Psychiatry"},{"issue":"Suppl 2","key":"10.1016\/j.ajp.2019.04.006_bib0140","first-page":"8","article-title":"3rd, Metabolic changes associated with antipsychotic use","volume":"6","author":"Lieberman","year":"2004","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2019.04.006_bib0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1467-789X.2005.00159.x","article-title":"Adiponectin: action, regulation and association to insulin sensitivity","volume":"6","author":"Lihn","year":"2005","journal-title":"Obes. Rev."},{"key":"10.1016\/j.ajp.2019.04.006_bib0150","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.schres.2018.01.011","article-title":"Leading causes of death among decedents with mention of schizophrenia on the death certificates in the United States","volume":"197","author":"Lin","year":"2018","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.ajp.2019.04.006_bib0155","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/bbrc.1996.0587","article-title":"cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose most abundant Gene transcript 1)","volume":"221","author":"Maeda","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.ajp.2019.04.006_bib0160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/0253-7176.119471","article-title":"Metabolic syndrome in schizophrenia","volume":"35","author":"Malhotra","year":"2013","journal-title":"Indian J. Psychol. Med."},{"issue":"2","key":"10.1016\/j.ajp.2019.04.006_bib0165","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ajcn\/84.2.328","article-title":"Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women","volume":"84","author":"Mantzoros","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"issue":"7","key":"10.1016\/j.ajp.2019.04.006_bib0170","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2337\/dc09-1392","article-title":"Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance","volume":"33","author":"Mente","year":"2010","journal-title":"Diabetes Care"},{"issue":"34","key":"10.1016\/j.ajp.2019.04.006_bib0175","doi-asserted-by":"crossref","first-page":"31629","DOI":"10.1074\/jbc.M212831200","article-title":"Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells","volume":"278","author":"Morrow","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ajp.2019.04.006_bib0180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.pcd.2010.05.006","article-title":"Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians","volume":"4","author":"Nayak","year":"2010","journal-title":"Prim. Care Diabetes"},{"issue":"2","key":"10.1016\/j.ajp.2019.04.006_bib0185","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/cen.12041","article-title":"Relationship between serum adiponectin levels and age in healthy subjects and patients with type 2 diabetes","volume":"79","author":"Obata","year":"2013","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"4","key":"10.1016\/j.ajp.2019.04.006_bib0190","doi-asserted-by":"crossref","first-page":"E624","DOI":"10.1152\/ajpendo.00502.2010","article-title":"Atypical antipsychotic drugs perturb AMPK-dependent regulation of hepatic lipid metabolism","volume":"300","author":"Oh","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.ajp.2019.04.006_bib0195","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.2337\/dc09-1130","article-title":"Changes in serum adiponectin concentrations correlate with changes in BMI, waist circumference, and estimated visceral fat area in middle-aged general population","volume":"32","author":"Okauchi","year":"2009","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ajp.2019.04.006_bib0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5152\/eajm.2011.08","article-title":"The effects of atypical antipsychotic usage duration on serum adiponectin levels and other metabolic parameters","volume":"43","author":"Oral","year":"2011","journal-title":"Eurasian J. Med."},{"issue":"5","key":"10.1016\/j.ajp.2019.04.006_bib0205","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2337\/diacare.26.5.1374","article-title":"Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study","volume":"26","author":"Orchard","year":"2003","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ajp.2019.04.006_bib0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ajp.2019.04.006_bib0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/2045125312464385","article-title":"The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review","volume":"3","author":"Papanastasiou","year":"2013","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.ajp.2019.04.006_bib0220","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1017\/S1461145714000157","article-title":"Metabolomic profiling of schizophrenia patients at risk for metabolic syndrome","volume":"17","author":"Paredes","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.ajp.2019.04.006_bib0225","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/MED.0b013e32833de61c","article-title":"Metabolic syndrome with the atypical antipsychotics","volume":"17","author":"Pramyothin","year":"2010","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"5","key":"10.1016\/j.ajp.2019.04.006_bib0230","first-page":"292","article-title":"Atypical antipsychotics and metabolic syndrome in patients with schizophrenia: risk factors, monitoring, and healthcare implications","volume":"4","author":"Riordan","year":"2011","journal-title":"Am. Health Drug Benefits"},{"issue":"7121","key":"10.1016\/j.ajp.2019.04.006_bib0235","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nature05483","article-title":"Adipocytes as regulators of energy balance and glucose homeostasis","volume":"444","author":"Rosen","year":"2006","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ajp.2019.04.006_bib0240","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.genm.2009.09.006","article-title":"Gender differences in adiponectin and low-grade inflammation among individuals with normal glucose tolerance, prediabetes, and type 2 diabetes","volume":"6","author":"Saltevo","year":"2009","journal-title":"Gend. Med."},{"issue":"4","key":"10.1016\/j.ajp.2019.04.006_bib0245","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.hjh.0000217840.26971.b6","article-title":"The metabolic syndrome: a glance at its history","volume":"24","author":"Sarafidis","year":"2006","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.ajp.2019.04.006_bib0250","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.schres.2013.07.044","article-title":"Elevated levels of adiponectin and other cytokines in drug naive, first episode schizophrenia patients with normal weight","volume":"150","author":"Song","year":"2013","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.ajp.2019.04.006_bib0255","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.dsx.2015.04.009","article-title":"Association of adipokines with metabolic disorders in patients with schizophrenia: results of comparative study with mental healthy cohort","volume":"9","author":"Tanyanskiy","year":"2015","journal-title":"Diabetes Metab. Syndr."},{"issue":"25","key":"10.1016\/j.ajp.2019.04.006_bib0260","doi-asserted-by":"crossref","first-page":"16309","DOI":"10.1073\/pnas.222657499","article-title":"Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation","volume":"99","author":"Tomas","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ajp.2019.04.006_bib0265","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41598-017-18709-9","article-title":"Plasma adiponectin levels and type 2 diabetes risk: a nested case-control study in a Chinese population and an updated meta-analysis","volume":"8","author":"Wang","year":"2018","journal-title":"Sci. Rep."},{"issue":"Oct. (5)","key":"10.1016\/j.ajp.2019.04.006_bib0270","first-page":"519","article-title":"Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study","volume":"27","author":"Westman","year":"2017","journal-title":"Epidemiol. Psychiatr. Sci."},{"issue":"5","key":"10.1016\/j.ajp.2019.04.006_bib0275","doi-asserted-by":"crossref","first-page":"e36868","DOI":"10.1371\/journal.pone.0036868","article-title":"Combined use of serum adiponectin and tumor necrosis factor-alpha receptor 2 levels was comparable to 2-hour post-load glucose in diabetes prediction","volume":"7","author":"Woo","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ajp.2019.04.006_bib0280","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.ajp.2019.04.006_bib0285","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2796.2009.02174.x","article-title":"Long-term effects of weight loss with a very low carbohydrate and low fat diet on vascular function in overweight and obese patients","volume":"267","author":"Wycherley","year":"2010","journal-title":"J. Intern. Med."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201819300826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201819300826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:32:19Z","timestamp":1761755539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201819300826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":57,"alternative-id":["S1876201819300826"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2019.04.006","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between serum adiponectin levels, cardiometabolic indices and metabolic syndrome in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2019.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}